Missed opportunities for the secondary prevention of cardiovascular disease in Canada

BACKGROUND: Strong evidence supports the use of antithrombotic agents (antiplatelets or oral anticoagulants), statins and angiotensin-converting enzyme inhibitors in patients with atherosclerotic cardiovascular disease; beta-blockers are additionally indicated in patients with coronary artery diseas...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hackam, Daniel G, Leiter, Lawrence A, Yan, Andrew T, Yan, Raymond T, Mendelsohn, Aurora, Tan, Mary, Zavodni, Louis, Chen, Richard, Tsang, Jennifer L, Kundi, Anjali, Lin, Peter J, Fitchett, David H, Langer, Anatoly, Goodman, Shaun G
Formato: Artigo
Idioma:Inglês
Publicado: Pulsus Group Inc 2007
Assuntos:
Clinical Studies
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2652002/
https://ncbi.nlm.nih.gov/pubmed/18060097
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares